Medindia

X

Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company

Tuesday, November 20, 2007 General News J E 4
Advertisement
NORTH BRANFORD, Conn., Nov. 19 M2D management announcesthe official launch of a progressive marketing and communications firm thatwill focus on the life sciences sector. M2D is the brainchild of twoindividuals with clear records of success in this highly regulated sector,Christine Lawton and Timothy Roe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071119/NEM104LOGO )

Christine is a respected meetings and events professional with almost twodecades of experience working on both the client and agency sides of thebusiness. Her accomplishments span several hundred meetings and conventionsof all varieties, both domestically and internationally, during herpharmaceutical tenure.

Timothy is a pharmaceutical and medical device professional with over 15years of progressively responsible positions in Sales and Marketing. Timothyis known in the industry as having the business acumen to maximize a product'sglobal commercial return and asset value. Timothy has managed the "Big-C"brands, Celebrex(R), Cipro(R) and Clarinex(R) as well as several smaller nicheproducts.

M2D provides tireless proactive thinking that eliminates problemsassociated with vendor complacency. Timothy Roe adds:

"As a former Product Manager, I recognize what is important to clients.Vendors should always add more detailed and proactive thought to their work,even after the 'honeymoon' period. There continues to be a tremendous needfor much higher performance, and smaller firms like M2D are already there.Those who can do it cost-effectively will win."

M2D's uniqueness results from a lifetime of client-side interactions withvendors. Clients receive genuine strategic attention, but the difference lieswith M2D's painstakingly detailed approach to tactical execution. The companyutilizes the most advanced analytics and metric reporting tools available andoffers them either gratis or at attractive pricing.

Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering-Plough respectively.M2D's core capabilities include: -- Thorough Understanding of Compliance Laws -- Lowest Guaranteed Travel Rates -- Investigator & Sales Meetings -- Conventions & Symposia; Ad Boards & Round Tables -- Opinion Leader & Speaker Bureau Management -- Promotional Peer-to-Peer Events -- CME-based Programming -- Surrogate Brand Management and Audits -- Advanced Webinars & Web Conferences with Real-Time Polling M2D's website www.m2details.com.

SOURCE Marketing and Meeting Details (M2D)
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
AMICAS Solutions 'Closing the Loop' in Radiology C...
S
EDDA Technology Introduces Universal Enterprise So...